Yupelri (revefenacin) is an inhalation solution that's used to treat adults with chronic obstructive pulmonary disease (COPD). It belongs to the drug class called long-acting muscarinic antagonists, or LAMAs. Yupelri (revefenacin) is inhaled through the mouth once a day using a nebulizer machine. Some possible side effects include headache and cough. Yupelri (revefenacin) is a brand-name medication; there's currently no generic version available.
Yupelri (revefenacin) is a long-acting muscarinic antagonist or LAMA.
When inhaled, the medication blocks the muscarinic receptors in your lungs. This helps open up the airways in your lungs, which helps you breathe easier.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Only taken once a day
Works quickly (within 5 minutes) and lasts the whole day
Easy to breathe in; there isn't as much timing and technique needed like for COPD inhalers
Must set up the nebulizer machine before each dose
Takes about 8 minutes to take a full dose
Not a good option for people with liver damage because of higher risk of side effects
Take Yupelri (revefenacin) only once at the same time every day. Don’t use Yupelri (revefenacin) to relieve any worsened, life-threatening, or sudden COPD symptoms. It’s important to keep your rescue inhaler, such as albuterol (Ventolin), by you so you can easily get to it and use it to relieve any sudden episodes of trouble breathing.
Let your prescriber know if you notice that Yupelri (revefenacin) isn't helping your COPD symptoms anymore even though you've been taking it once every day. Also talk to your prescriber if you need to use your rescue inhaler more often than usual. This might mean that your COPD has gotten worse and you might need a different medication to manage your lung condition.
Don’t stop taking Yupelri (revefenacin) without talking to your prescriber first. Otherwise, your COPD symptoms, such as shortness of breath and wheezing, can come back.
Keep each vial of Yupelri (revefenacin) in their original foil pouch until you’re ready to use it. This helps protect the medication from light.
How to use Yupelri (revefenacin):
Carefully review the instructions for use for Yupelri (revefenacin). You must use a standard jet nebulizer machine with Yupelri (revefenacin). Ask your prescriber or pharmacist if you have questions about how to take the medication using your nebulizer machine.
Don’t inject or swallow the inhalation solution. Also don’t mix other medications with Yupelri (revefenacin) in the nebulizer.
How to set up your nebulizer: Open the foil pouch containing the Yupelri (revefenacin) vial, carefully twist open the vial, and then use it right away. Check that the solution in the vial is clear and colorless. Squeeze all of the solution in the vial into the nebulizer cup. Then, connect the mouthpiece to the nebulizer cup with the valve facing up. Next, connect the nebulizer cup to the compressor using the tubing.
How to take your Yupelri (revefenacin) dose: Make sure you’re sitting straight in a comfortable position. Place the mouthpiece in your mouth, and then turn on the compressor to start your dose. Breathe through your mouth calmly, deeply, and evenly until you don’t see any more mist in the nebulizer cup. It usually takes about 8 minutes to take a full dose. Once done, turn off the compressor.
Throw each plastic vial away right after you pour the solution into the nebulizer cup, even if there's still some medication left in the vial. Young children are at risk of choking if they accidentally put the small vials into their mouth.
Clean and store your nebulizer by following the manufacturer's instructions.
Yupelri (revefenacin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Many inhaled medications, including Yupelri (revefenacin), can suddenly worsen your breathing problems and cause more wheezing. This can be life-threatening. Be sure to have a rescue inhaler handy to treat and relieve sudden worsened breathing; don't use Yupelri (revefenacin) in this situation.
Risk factors: Narrow-angle glaucoma
Yupelri (revefenacin) can raise the pressure in your eyes. This can cause new or worsening narrow-angle glaucoma, which is serious and needs medical attention. Contact a healthcare professional or your optometrist if you have any symptoms like eye pain or discomfort, blurry vision, seeing bright colors or halos around lights, or eye redness.
Risk factors: Urinary retention (can't urinate) | Enlarged prostate | Bladder-neck blockage
Yupelri (revefenacin) can make you have trouble urinating or have pain while urinating. This medication can worsen these symptoms if you have an enlarged prostate or other medical conditions that make you have trouble urinating. Talk with your prescriber right away if you notice that you have any new or worsening problems with urination while you're taking Yupelri (revefenacin).
It's possible to have a serious allergic reaction right after you take your Yupelri (revefenacin) dose. Stop taking this medication and get emergency care right away if you have trouble breathing; rash; hives; or swelling of your face, mouth, or throat. You'll probably need to switch to a different COPD maintenance medication.
The typical dose is 175 mcg (1 vial) inhaled into the lungs once a day using a nebulizer. The nebulizer helps turn the medication into a mist that you inhale through your mouth and into your lungs.
Maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults
Chronic obstructive pulmonary disease (COPD)
Asthma in people age 6 years and older - Spiriva Respimat only
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Thoracic Society. (2020). Nebulizer breathing treatments at home. American Journal of Respiratory and Critical Care Medicine.
Buels, K. S., et al. (2012). Muscarinic receptor antagonists: Effects on pulmonary function. Handbook of Experimental Pharmacology.
Global Initiative for Chronic Obstructive Lung Disease. (2024). Pocket guide to COPD diagnosis, management, and prevention: A guide for health care prevention.
Maqsood, M. H., et al. (2019). The role of revefenacin in chronic obstructive pulmonary disease. Cureus.
Mylan Specialty L.P. (2022). Yupelri- revefenacin solution [package insert]. DailyMed.
National Heart, Lung, and Blood Institute. (2021). How to use a nebulizer fact sheet.
National Institute of Diabetes and Digestive and Kidney Diseases. (2019). Symptoms & causes of urinary retention.
ScienceDirect. (2011). Maintenance pharmacotherapy of mild and moderate COPD: What is the evidence? Respiratory Medicine.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.